Karyopharm Therapeutics Inc. (KPTI)
NASDAQ · Healthcare
Karyopharm Therapeutics Inc. Total Liabilities 2011–2025
Karyopharm Therapeutics Inc. annual total liabilities history from 2012 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Karyopharm Therapeutics Inc. total liabilities as of December 31, 2025: 401.3M, a 14.53% increase year-over-year.
- Karyopharm Therapeutics Inc. total liabilities for 2025 were 401.3M, a 14.53% increase from 2024.
- Karyopharm Therapeutics Inc. total liabilities for 2024 were 350.4M, a 6.96% decrease from 2023.
- Karyopharm Therapeutics Inc. total liabilities for 2023 were 376.6M, a 0.48% increase from 2022.
- Karyopharm Therapeutics Inc. total liabilities for 2022 were 374.8M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Karyopharm Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $401 |
| 2024 | $350 |
| 2023 | $377 |
| 2022 | $375 |
| 2021 | $385 |
| 2020 | $263 |
| 2019 | $245 |
| 2018 | $158 |
| 2017 | $51 |
| 2016 | $18 |
| 2015 | $17 |
| 2014 | $14 |
| 2013 | $3 |
| 2012 | $29 |
Karyopharm Therapeutics Inc. Total Liabilities — FAQ
Karyopharm Therapeutics Inc. (KPTI) total liabilities over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KPTI's total liabilities history?
The chart and table above show Karyopharm Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.